Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer

NCT03096847 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

502

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Metastatic Breast Cancer

Interventions

DRUG: ribociclib
DRUG: letrozole
DRUG: goserelin

Sponsor

Novartis Pharmaceuticals